NuCana PLC (NCNA)
1.23
-0.04
(-3.15%)
USD |
NASDAQ |
Nov 22, 16:00
1.235
0.00 (0.00%)
After-Hours: 20:00
NuCana Cash from Investing (Quarterly): -0.0053M for June 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -0.0053M |
| March 31, 2024 | 0.0545M |
| December 31, 2023 | 0.0038M |
| September 30, 2023 | 3.357M |
| June 30, 2023 | 0.0347M |
| March 31, 2023 | 0.1981M |
| December 31, 2022 | 0.1957M |
| September 30, 2022 | 0.1101M |
| June 30, 2022 | 0.024M |
| March 31, 2022 | -0.1811M |
| December 31, 2021 | -0.6276M |
| September 30, 2021 | -3.855M |
| June 30, 2021 | -0.2539M |
| March 31, 2021 | -0.1627M |
| December 31, 2020 | -0.2262M |
| Date | Value |
|---|---|
| September 30, 2020 | -0.7905M |
| June 30, 2020 | -0.3852M |
| March 31, 2020 | -0.2833M |
| December 31, 2019 | -0.0595M |
| September 30, 2019 | 0.0452M |
| June 30, 2019 | -0.1879M |
| March 31, 2019 | 0.0169M |
| December 31, 2018 | -0.2967M |
| September 30, 2018 | -0.0009M |
| June 30, 2018 | -0.425M |
| March 31, 2018 | -0.146M |
| December 31, 2017 | -0.1731M |
| September 30, 2017 | -0.5215M |
| June 30, 2017 | -0.2747M |
| March 31, 2017 | -0.2353M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-3.855M
Minimum
Sep 2021
3.357M
Maximum
Sep 2023
-0.1501M
Average
-0.0595M
Median
Dec 2019
Cash from Investing (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | -66.02M |
| Biodexa Pharmaceuticals PLC | -- |
| TC BioPharm (Holdings) PLC | -0.0071M |
| Mereo BioPharma Group PLC | 0.00 |
| Autolus Therapeutics PLC | -9.589M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.446M |
| Cash from Financing (Quarterly) | -0.0888M |
| Free Cash Flow | -22.00M |
| Free Cash Flow Per Share (Quarterly) | -0.6922 |
| Free Cash Flow Yield | -828.9% |